posted on 2018-09-07, 14:28authored byObolbek Turapov, Francesca Forti, Baleegh Kadhim, Daniela Ghisotti, Jad Sassine, Anna Straatman-Iwanowska, Andrew Bottrill, Patrick J. Moynihan, Russell Wallis, Philippe Barthe, Martin Cohen-Gonsaud, Paul Ajuh, Waldemar Vollmer, Galina V. Mukamolova
Tuberculosis claims over one million lives annually and its causative agent Mycobacterium
tuberculosis is a highly successful pathogen. Protein kinase B (PknB) is reported to be
critical for mycobacterial growth. Here, we demonstrate that PknB-depleted M. tuberculosis
can replicate normally and can synthesise peptidoglycan in osmoprotective medium.
Comparative phosphoproteomics of PknB-producing and PknB-depleted mycobacteria
identifies CwlM, an essential regulator of peptidoglycan synthesis, as a major PknB
substrate. Our complementation studies of a cwlM mutant of M. tuberculosis support CwlM
phosphorylation as a likely molecular basis for PknB being essential for mycobacterial
growth. We demonstrate that growing mycobacteria produce two forms of CwlM : a nonphosphorylated
membrane-associated form and a PknB-phosphorylated cytoplasmic form.
Furthermore we show that the partner proteins for the phosphorylated and nonphosphorylated
forms of CwlM are FhaA, a fork-head-associated domain protein, and MurJ,
a proposed Lipid II flippase, respectively. From our results, we propose a model in which
CwlM potentially regulates both the biosynthesis of peptidoglycan precursors and their
transport across the cytoplasmic membrane.
Funding
M. tuberculosis genomic DNA, anti-GroEL and anti-GlnA1 antibodies were provided by
Colorado State University (Contract No. HHSN266200400091C; NIH, NIAID N01-AI-40091).
We acknowledge the Centre for Core Biotechnology Services at the University of Leicester
for support with containment level 3 experiments, imaging of M. tuberculosis and analysis of
mycobacterial proteins. We are grateful to Bandar Alrashid for the cloning of cwsA in
pUAB400, Oliver Sampson for optimisation of MurJICD expression and Angélique DeVisch for
assistance with the FhaA binding experiments. The project was supported by the UK
Biotechnology and Biological Sciences Research Council grants BB/H008586/1 and
BB/P001513/1 (GVM), BB/P001289/1 (WV) and Future Leaders Fellowship BB/N011945/1
(PM); the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INBS-05
grant (MCG) and the High Committee of Educational Development in Iraq (BK).
History
Citation
Cell Reports, 2018, 25(1), pp. 57-67.e5
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Infection, Immunity and Inflammation